106 related articles for article (PubMed ID: 15316171)
21. Anti-p200 pemphigoid: diagnosis and treatment of a case presenting as an inflammatory subepidermal blistering disease.
Egan CA; Yee C; Zillikens D; Yancey KB
J Am Acad Dermatol; 2002 May; 46(5):786-9. PubMed ID: 12004326
[TBL] [Abstract][Full Text] [Related]
22. From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid.
Dainichi T; Koga H; Tsuji T; Ishii N; Ohyama B; Ueda A; Natsuaki Y; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
J Dermatol; 2010 Mar; 37(3):231-8. PubMed ID: 20507386
[TBL] [Abstract][Full Text] [Related]
23. Pemphigoid nodularis associated with autoantibodies to the NC16A domain of BP180 and a hyperproliferative integrin profile.
Schachter M; Brieva JC; Jones JC; Zillikens D; Skrobek C; Chan LS
J Am Acad Dermatol; 2001 Nov; 45(5):747-54. PubMed ID: 11606928
[TBL] [Abstract][Full Text] [Related]
24. A patient with both bullous pemphigoid and epidermolysis bullosa acquisita: an example of intermolecular epitope spreading.
Fairley JA; Woodley DT; Chen M; Giudice GJ; Lin MS
J Am Acad Dermatol; 2004 Jul; 51(1):118-22. PubMed ID: 15243536
[TBL] [Abstract][Full Text] [Related]
25. [Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)].
Raffin D; Delaplace M; Roussel A; Estève E
Ann Dermatol Venereol; 2013 Dec; 140(12):784-7. PubMed ID: 24315224
[TBL] [Abstract][Full Text] [Related]
26. [Anti-p200 pemphigoid: a spectacular response to dapsone].
Munsch C; Prey S; Joly P; Meyer N; Lamant L; Livideanu C; Viraben R; Paul C
Ann Dermatol Venereol; 2011 Nov; 138(11):739-42. PubMed ID: 22078034
[TBL] [Abstract][Full Text] [Related]
27. A bullous skin disease patient with autoantibodies against separate epitopes in 1 mol/L sodium chloride split skin.
Domloge-Hultsch N; Benson P; Gammon WR; Yancey KB
Arch Dermatol; 1992 Aug; 128(8):1096-101. PubMed ID: 1379792
[TBL] [Abstract][Full Text] [Related]
28. IgA anti-p200 pemphigoid.
Wozniak K; Hashimoto T; Fukuda S; Ohyama B; Ishii N; Koga H; Dainichi T; Kowalewski C
Arch Dermatol; 2011 Nov; 147(11):1306-10. PubMed ID: 22106117
[TBL] [Abstract][Full Text] [Related]
29. A practical technique for differentiation of subepidermal bullous diseases: localization of in vivo-bound IgG by laser scanning confocal microscopy.
Wozniak K; Kazama T; Kowalewski C
Arch Dermatol; 2003 Aug; 139(8):1007-11. PubMed ID: 12925388
[TBL] [Abstract][Full Text] [Related]
30. A Korean case of anti-p200 pemphigoid.
Cho SB; Kim SC
Yonsei Med J; 2003 Oct; 44(5):931-4. PubMed ID: 14584115
[TBL] [Abstract][Full Text] [Related]
31. Epidermolysis bullosa acquisita: report of a case with comparison of immunogold electron microscopy using pre- and postembedding labelling.
Ishiko A; Hashimoto T; Shimizu H; Nishikawa T
Br J Dermatol; 1996 Jan; 134(1):147-51. PubMed ID: 8745903
[TBL] [Abstract][Full Text] [Related]
32. A novel 105-kDa lamina lucida autoantigen: association with bullous pemphigoid.
Cotell SL; Lapiere JC; Chen JD; Iwasaki T; Krusinski PA; Chan LS; Woodley DT
J Invest Dermatol; 1994 Jul; 103(1):78-83. PubMed ID: 8027584
[TBL] [Abstract][Full Text] [Related]
33. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice.
Borradori L; Caldwell JB; Briggaman RA; Burr CE; Gammon WR; James WD; Yancey KB
Arch Dermatol; 1995 May; 131(5):590-5. PubMed ID: 7741548
[TBL] [Abstract][Full Text] [Related]
34. A case of linear IgA bullous dermatosis with IgA anti-type VII collagen autoantibodies.
Hashimoto T; Ishiko A; Shimizu H; Tanaka T; Dodd HJ; Bhogal BS; Black MM; Nishikawa T
Br J Dermatol; 1996 Feb; 134(2):336-9. PubMed ID: 8746352
[TBL] [Abstract][Full Text] [Related]
35. U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases.
Vodegel RM; Jonkman MF; Pas HH; de Jong MC
Br J Dermatol; 2004 Jul; 151(1):112-8. PubMed ID: 15270879
[TBL] [Abstract][Full Text] [Related]
36. Anti-epiligrin cicatricial pemphigoid: a case associated with gastric carcinoma and features resembling epidermolysis bullosa acquisita.
Fujimoto W; Ishida-Yamamoto A; Hsu R; Nagao Y; Iizuka H; Yancey KB; Arata J
Br J Dermatol; 1998 Oct; 139(4):682-7. PubMed ID: 10025973
[TBL] [Abstract][Full Text] [Related]
37. A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone.
Zillikens D; Kawahara Y; Ishiko A; Shimizu H; Mayer J; Rank CV; Liu Z; Giudice GJ; Tran HH; Marinkovich MP; Brocker EB; Hashimoto T
J Invest Dermatol; 1996 Jun; 106(6):1333-8. PubMed ID: 8752680
[TBL] [Abstract][Full Text] [Related]
38. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.
Izumi R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Watanabe R; Kuwano Y; Kurokawa M; Hashimoto T; Tamaki K
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049
[TBL] [Abstract][Full Text] [Related]
39. Epidermolysis bullosa acquisita of the immunopathological type (dermolytic pemphigoid).
Briggaman RA; Gammon WR; Woodley DT
J Invest Dermatol; 1985 Jul; 85(1 Suppl):79s-84s. PubMed ID: 4008982
[TBL] [Abstract][Full Text] [Related]
40. A case of mixed bullous disease of epidermolysis bullosa acquisita and linear IgA bullous dermatosis.
Osawa M; Demitsu T; Toda S; Yokokura H; Umemoto N; Yamada T; Yoneda K; Kakurai M; Yoshida M; Hashimoto T
Dermatology; 2005; 211(2):146-8. PubMed ID: 16088162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]